Uridine–cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine
Zhen Xu, Christoffer Flensburg, Rebecca A Bilardi, Ian J Majewski · 2023
Read Uridine–cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine by Zhen Xu, Christoffer Flensburg, Rebecca A Bilardi, Ian J Majewski (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10711452.txt.
Description
Zhen Xu and co-authors study a safety question about the antiviral drug molnupiravir in a 2023 paper. The drug was approved for treating COVID-19, and its active form is known to cause mutations in DNA in lab tests. Yet animal studies done for approval did not show the same harm, and the team wanted to know why results differ.
Using a CRISPR screen, they found that a gene called Uck2 helps the drug's active form change DNA. Cells without the gene tolerated the drug better, while cells with extra copies mutated more. The gene is often switched on at high levels in cancers. The authors argue that differences in how cells handle such building blocks help explain the mixed test results.
Catalog record
| CREATOR | Zhen Xu, Christoffer Flensburg, Rebecca A Bilardi, Ian J Majewski |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |